SA¹ú¼Ê´«Ã½

Tuesday 22 October 2024
Salisbury Foundation Trust

FOI_6584

Internal Reference Number: FOI_6584

Date Request Received: 11/05/2022 00:00:00

Date Request Replied To: 24/05/2022 00:00:00

This response was sent via: By Email

Request Summary: Intra-vitreal injections or implants

Request Category: Companies

 
Question Number 1:
I am analysing the usage of intra-vitreal injections or implants by the NHS. I would greatly appreciate if you could answer the following questions:

How many of the following intra-vitreal injections/implants has your trust administered in the four-month period from January to April 2022:

• Aflibercept

• Bevacizumab

• Brolucizumab

• Dexamethasone

• Fluocinolone acetonide

• Ranibizumab


 
Answer To Question 1:
Aflibercept 1657
Bevacizumab 9
Brolucizumab 0
Dexamethasone 14
Fluocinolone Acetonide <5
Ranibizumab 47
 
Question Number 2:
Please provide the number of injections/implants by eye condition for the four-month period from January to April 2022.


Eye Conditions - Wet Age-Related Macular Degeneration wAMD


Aflibercept

Bevacizumab

Brolucizumab

Dexamethasone

Fluocinolone acetonide

Ranibizumab


 
Answer To Question 2:
Aflibercept 1164
Bevacizumab 6
Brolucizumab 0
Dexamethasone 0
Fluocinolone Acetonide 0
Ranibizumab 43
 
Question Number 3:
Please provide the number of injections/implants by eye condition for the four-month period from January to April 2022.

Eye Condition - Diabetic Macular Degeneration DMO

Aflibercept

Bevacizumab

Brolucizumab

Dexamethasone

Fluocinolone acetonide

Ranibizumab
 
Answer To Question 3:
Aflibercept 190
Bevacizumab 0
Brolucizumab 0
Dexamethasone 9
Fluocinolone Acetonide <5
Ranibizumab 0
 
Question Number 4:
Please provide the number of injections/implants by eye condition for the four-month period from January to April 2022.

Eye Conditions - Retinal Vein Occulusion RVO

Aflibercept

Bevacizumab

Brolucizumab

Dexamethasone

Fluocinolone acetonide

Ranibizumab
 
Answer To Question 4:
Aflibercept 236
Bevacizumab 0
Brolucizumab 0
Dexamethasone <5
Fluocinolone Acetonide 0
Ranibizumab <5
 
To return to the list of all the FOI requests please click here

Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

SA¹ú¼Ê´«Ã½, SA¹ú¼Ê´«Ã½ Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2024 SA¹ú¼Ê´«Ã½
Trust Values